Navigate this market better. Subscribe for FREE stock alerts and information.

Friday, June 20, 2014

AbbVie says Shire rejected bid approach, (NYSE: ABBV)

U.S. drugmaker AbbVie Inc confirmed on Friday it had made a bid approach to Shire , which was rejected by the British group's board. It said talks were no longer ongoing. AbbVie was responding to a Reuters story on Thursday which revealed the talks.

AbbVie Inc. (AbbVie) is a research-based pharmaceuticals company. Shares of ABBV fell by 0.7% or $-0.38/share to $54.19. In the past year, the shares have traded as low as $41.07 and as high as $55.40. On average, 5701390 shares of ABBV exchange hands on a given day and today's volume is recorded at 3960078.